225 related articles for article (PubMed ID: 28893473)
1. Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines.
Neuzil KM; Bresee JS; de la Hoz F; Johansen K; Karron RA; Krishnan A; Madhi SA; Mangtani P; Spiro DJ; Ortiz JR;
Vaccine; 2017 Oct; 35(43):5734-5737. PubMed ID: 28893473
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine programs for children in low- and middle-income countries: current status and way forward.
Ortiz JR; Neuzil KM
Expert Rev Vaccines; 2019 Jul; 18(7):711-724. PubMed ID: 31226895
[No Abstract] [Full Text] [Related]
3. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.
Ortiz JR; Hickling J; Jones R; Donabedian A; Engelhardt OG; Katz JM; Madhi SA; Neuzil KM; Rimmelzwaan GF; Southern J; Spiro DJ; Hombach J
Vaccine; 2018 Feb; 36(7):932-938. PubMed ID: 29221895
[TBL] [Abstract][Full Text] [Related]
4. Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines.
Ortiz JR; Neuzil KM
J Infect Dis; 2019 Apr; 219(Suppl_1):S97-S106. PubMed ID: 30715348
[TBL] [Abstract][Full Text] [Related]
5. Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
Ba-Nguz A; Shah A; Bresee JS; Lafond KE; Cavallaro K; Shefer A; Donadel M; Seward JF
Vaccine; 2019 Jun; 37(28):3646-3653. PubMed ID: 31130258
[TBL] [Abstract][Full Text] [Related]
6. Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.
Fell DB; Azziz-Baumgartner E; Baker MG; Batra M; Beauté J; Beutels P; Bhat N; Bhutta ZA; Cohen C; De Mucio B; Gessner BD; Gravett MG; Katz MA; Knight M; Lee VJ; Loeb M; Luteijn JM; Marshall H; Nair H; Pottie K; Salam RA; Savitz DA; Serruya SJ; Skidmore B; Ortiz JR;
Vaccine; 2017 Oct; 35(43):5738-5750. PubMed ID: 28867508
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
[TBL] [Abstract][Full Text] [Related]
8. Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines.
Ortiz JR; Hombach J
Vaccine; 2018 Sep; 36(37):5504-5505. PubMed ID: 29042200
[TBL] [Abstract][Full Text] [Related]
9. Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness.
Ruscio B; Bolster A; Bresee J;
Vaccine; 2020 Apr; 38(16):3179-3183. PubMed ID: 32171576
[TBL] [Abstract][Full Text] [Related]
10. A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.
Ortiz JR; Perut M; Dumolard L; Wijesinghe PR; Jorgensen P; Ropero AM; Danovaro-Holliday MC; Heffelfinger JD; Tevi-Benissan C; Teleb NA; Lambach P; Hombach J
Vaccine; 2016 Oct; 34(45):5400-5405. PubMed ID: 27646030
[TBL] [Abstract][Full Text] [Related]
11. Seasonal influenza vaccination in middle-income countries: Assessment of immunization practices in Belarus, Morocco, and Thailand.
Mantel C; Chu SY; Hyde TB; Lambach P;
Vaccine; 2020 Jan; 38(2):212-219. PubMed ID: 31699507
[TBL] [Abstract][Full Text] [Related]
12. Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
Kraigsley AM; Moore KA; Bolster A; Peters M; Richardson D; Arpey M; Sonnenberger M; McCarron M; Lambach P; Maltezou HC; Bresee JS
Vaccine; 2021 Jun; 39(25):3419-3427. PubMed ID: 33992439
[TBL] [Abstract][Full Text] [Related]
13. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
[TBL] [Abstract][Full Text] [Related]
14. The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
Bresee JS; Lafond KE; McCarron M; Azziz-Baumgartner E; Chu SY; Ebama M; Hinman AR; Xeuatvongsa A; Bino S; Richardson D; Porter RM; Moen A; McKinlay M;
Vaccine; 2019 Aug; 37(35):5089-5095. PubMed ID: 31288998
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.
Breteler JK; Tam JS; Jit M; Ket JC; De Boer MR
Vaccine; 2013 Oct; 31(45):5168-77. PubMed ID: 24012574
[TBL] [Abstract][Full Text] [Related]
16. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
Hendriks J; Hutubessy RCW; Grohmann G; Torelli G; Friede M; Kieny MP
Vaccine; 2018 Jun; 36(28):3993-3997. PubMed ID: 29866617
[TBL] [Abstract][Full Text] [Related]
18. Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.
Fleming JA; Baltrons R; Rowley E; Quintanilla I; Crespin E; Ropero AM; Ortiz JR; Lambach P; Neuzil KM; Stepanchak M; Hombach J; Bhat N
Vaccine; 2018 Jun; 36(28):4054-4061. PubMed ID: 29859803
[TBL] [Abstract][Full Text] [Related]
19. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C
Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683
[TBL] [Abstract][Full Text] [Related]
20. Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
Nannei C; Goldin S; Torelli G; Fatima H; Kumar K; Bubb-Humfryes O; Stenson B; Sparrow E
Vaccine; 2016 Oct; 34(45):5393-5399. PubMed ID: 27646029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
